{
    "2021-12-28": [
        [
            {
                "time": "",
                "original_text": "华大基因两款肿瘤基因检测产品获欧盟CE准入资质",
                "features": {
                    "keywords": [
                        "华大基因",
                        "肿瘤",
                        "基因检测",
                        "欧盟",
                        "CE认证"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华大基因董事长汪建合计增持0.07%股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "汪建",
                        "增持",
                        "股份"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因(300676.SZ)：实控人增持期过半 累计增持30.11万股",
                "features": {
                    "keywords": [
                        "华大基因",
                        "实控人",
                        "增持",
                        "股份"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因(300676.SZ)实控人汪建已增持30.11万股 增持时间过半",
                "features": {
                    "keywords": [
                        "华大基因",
                        "汪建",
                        "增持",
                        "股份"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：建立了基于本地化基因检测分析解决方案的一体机HALOS",
                "features": {
                    "keywords": [
                        "华大基因",
                        "本地化",
                        "基因检测",
                        "HALOS"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华大基因：2021年上半年，公司在美洲地区的收入金额为227,384,596.63元人民币",
                "features": {
                    "keywords": [
                        "华大基因",
                        "美洲",
                        "收入",
                        "2021年上半年"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}